Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 41% ± 17% | |
fibroblast | 11 studies | 32% ± 13% | |
mesothelial cell | 9 studies | 45% ± 14% | |
smooth muscle cell | 9 studies | 31% ± 10% | |
endothelial cell | 8 studies | 28% ± 16% | |
type I pneumocyte | 8 studies | 59% ± 24% | |
oligodendrocyte | 8 studies | 28% ± 10% | |
adipocyte | 7 studies | 27% ± 7% | |
cardiac muscle cell | 6 studies | 59% ± 24% | |
interneuron | 5 studies | 31% ± 9% | |
epithelial cell | 5 studies | 30% ± 13% | |
GABAergic neuron | 5 studies | 27% ± 10% | |
type II pneumocyte | 5 studies | 32% ± 10% | |
myofibroblast cell | 4 studies | 39% ± 14% | |
connective tissue cell | 4 studies | 25% ± 7% | |
pericyte | 4 studies | 25% ± 4% | |
glutamatergic neuron | 3 studies | 32% ± 11% | |
glial cell | 3 studies | 25% ± 1% | |
granule cell | 3 studies | 48% ± 0% | |
macrophage | 3 studies | 34% ± 21% | |
Mueller cell | 3 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 97% | 954.82 | 175 / 180 | 96% | 8.89 | 413 / 430 |
prostate | 94% | 552.61 | 230 / 245 | 93% | 4.46 | 467 / 502 |
pancreas | 97% | 579.16 | 318 / 328 | 89% | 5.43 | 159 / 178 |
lung | 98% | 870.86 | 569 / 578 | 76% | 4.09 | 880 / 1155 |
skin | 98% | 1091.71 | 1775 / 1809 | 76% | 4.03 | 358 / 472 |
breast | 93% | 429.29 | 426 / 459 | 79% | 3.52 | 888 / 1118 |
esophagus | 92% | 452.85 | 1329 / 1445 | 79% | 4.96 | 144 / 183 |
stomach | 100% | 1016.50 | 359 / 359 | 71% | 5.84 | 202 / 286 |
uterus | 97% | 913.91 | 165 / 170 | 48% | 3.46 | 219 / 459 |
intestine | 89% | 793.41 | 864 / 966 | 54% | 2.59 | 287 / 527 |
bladder | 90% | 730.29 | 19 / 21 | 38% | 1.43 | 192 / 504 |
kidney | 28% | 85.61 | 25 / 89 | 86% | 4.05 | 774 / 901 |
blood vessel | 100% | 2164.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
thymus | 35% | 93.07 | 231 / 653 | 62% | 2.21 | 378 / 605 |
adipose | 97% | 689.01 | 1171 / 1204 | 0% | 0 | 0 / 0 |
heart | 89% | 586.27 | 762 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 40% | 98.73 | 104 / 258 | 37% | 0.98 | 86 / 230 |
spleen | 72% | 212.70 | 174 / 241 | 0% | 0 | 0 / 0 |
brain | 18% | 57.88 | 478 / 2642 | 46% | 1.53 | 322 / 705 |
tonsil | 0% | 0 | 0 / 0 | 56% | 1.68 | 25 / 45 |
muscle | 29% | 64.64 | 234 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 2.43 | 2 / 226 | 26% | 1.14 | 107 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.46 | 5 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
peripheral blood | 2% | 3.64 | 15 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007605 | Biological process | sensory perception of sound |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0007275 | Biological process | multicellular organism development |
GO_0048839 | Biological process | inner ear development |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0014002 | Biological process | astrocyte development |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0043679 | Cellular component | axon terminus |
GO_0009986 | Cellular component | cell surface |
GO_0001725 | Cellular component | stress fiber |
GO_0005737 | Cellular component | cytoplasm |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ROR1 |
Protein name | ROR1 protein Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1) |
Synonyms | NTRKR1 |
Description | FUNCTION: Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo . Receptor for ligand WNT5A which activate downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling . In inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells . . |
Accessions | A2VCQ3 Q01973 ENST00000371079.6 [Q01973-1] ENST00000371080.5 [Q01973-3] |